Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

89bio Inc

ETNB
Current price
8.4 USD +0.36 USD (+4.48%)
Last closed 8.04 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 635 363 328 USD
Yield for 12 month +0.72 %
Week
Month
Year
ETNB
21.11.2021 - 28.11.2021

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California. Address: 142 Sansome Street, San Francisco, CA, United States, 94104

Analytics

WallStreet Target Price

32.44 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ETNB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -135 311 008 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -25.61 %
PEG Ratio
Return On Equity TTM -44.97 %
Wall Street Target Price 32.44 USD
Revenue TTM
Book Value 5.42 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -1.8 USD
Diluted Eps TTM -1.8 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ETNB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ETNB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ETNB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -1.7368
Price Book MRQ 1.5489

Financials ETNB

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ETNB

For 52 weeks

6.58 USD 22.93 USD
50 Day MA 9.47 USD
Shares Short Prior Month 5 433 950
200 Day MA 14.78 USD
Short Ratio 3.93
Shares Short 6 038 483
Short Percent 9.45 %